UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043664
Receipt number R000049862
Scientific Title The outcome of Embryo and oocyte and ovarian tissue in JAPAN (2021)
Date of disclosure of the study information 2021/04/01
Last modified on 2021/03/18 19:37:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The outcome of fertility preservation treatment in JAPAN (2021)

Acronym

The outcome of fertility preservation treatment in JAPAN (2021)

Scientific Title

The outcome of Embryo and oocyte and ovarian tissue in JAPAN (2021)

Scientific Title:Acronym

The outcome of Embryo and oocyte and ovarian tissue in JAPAN (2021)

Region

Japan


Condition

Condition

Breast cancer, hematological cancer, and so on

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Verification of the efficacy of fertility preservation treatment

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Live birth rate

Key secondary outcomes

pregnancy rate, the numbers of extracted oocyte, and so on.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 days-old <=

Age-upper limit

50 years-old >=

Gender

Female

Key inclusion criteria

The patient who underwent embryo, oocyte, or ovarian tissue cryopreservation as fertility preservation treatment.

Key exclusion criteria

The patients who decline to contribute the present study.

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name NAO
Middle name
Last name SUZUKI

Organization

St. Marianna University School of Medicine

Division name

Obstetrics and Gynecology

Zip code

216-8511

Address

2-16-1 Sugao, Miyamae-ku, Kawasaki city, Kanagawa, JAPAN

TEL

044-977-8111

Email

nao@marianna-u.ac.jp


Public contact

Name of contact person

1st name SEIDO
Middle name
Last name TAKAE

Organization

St. Marianna University School of Medicine

Division name

Obstetrics and Gynecology

Zip code

216-8511

Address

2-16-1 Sugao, Miyamae-ku, Kawasaki city, Kanagawa, JAPAN

TEL

044-977-8111

Homepage URL


Email

s2takae@marianna-u.ac.jp


Sponsor or person

Institute

St. Marianna University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Health and Welfare Ministry

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Certified Review Board of St. Marianna University

Address

2-16-1 Sugao, Miyamae-ku, Kawasaki city, Kanagawa, JAPAN

Tel

044-977-8111

Email

k-sienbu.mail@marianna-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 03 Month 17 Day

Date of IRB


Anticipated trial start date

2021 Year 04 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Questionnaire sheet will be sent to the institution and hospital which are registered Japan society of Obstetrics and Gynecology, for investigating the numbers of case, and outcome of treatment. Also, the outcome which are already investigated will be include to present study (already we got the permission).


Management information

Registered date

2021 Year 03 Month 18 Day

Last modified on

2021 Year 03 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049862


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name